.jpg)
Despite the end of federal shortages of popular GLP-1 weight-loss medications, the market for compounded alternatives remains strong – and some patients may unknowingly be receiving products from pharmacies with concerning regulatory histories, according to new research from the University of Colorado Anschutz.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
NEW YORK–(BUSINESS WIRE)–St. John’s University, a renowned university known for its commitment to providing excellence in education, is proud to announce a new partnership with Perspectus, a Colorado-based leader in virtual reality (VR) technology. This […]
Following over a year of sanctions, the company doesn’t expect to see its first Colorado enrollee until March. Click here to view original post
Recent headlines in the United Kingdom earlier this year attributed noise-cancelling headphones as a possible culprit in rising rates of auditory processing disorder (APD) and hearing problems in younger populations. While the APD theory is […]
Copyright © 2026 Biotech Networks
